Cells derived from obese Type 2 diabetes (T2D) patients show increased expression of inflammatory markers, activation of the NLRP3 inflammasome, and a greater capacity for migration and phagocytosis than those derived from lean donors. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.